AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 302 min read$BTSG

BrightSpring Health Services 3Q 2026: Revenue $4.21B, Net income $100.1M, EPS $0.45— 10-Q Summary

BrightSpring Health Services reported 3Q 2026 revenue of $4.21B, up 26.4% YoY, with net income of $100.1M and EPS of $0.45. Growth was driven by Pharmacy Solutions and Provider Services, including contributions from recent acquisitions.

Original reporting
tradingview.com
Published Oct 30, 2026, 12:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 12:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
BrightSpring Health Services 3Q 2026: Revenue $4.21B, Net income $100.1M, EPS $0.45— 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$BTSGBullishHigh
01

Why it matters

The earnings release shows robust growth, likely prompting a positive price reaction, though segmental declines and integration risks warrant caution.

02

Market read

Strong earnings could drive BTSG stock higher in the near term.

03

What to watch

Integration risk from recent acquisitions of Amedisys and LHC branches may temper upside.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Summary of BrightSpring Health Services' Q3 2026 10‑Q filing, highlighting revenue, earnings, and business segment performance.

Company-level read

Ticker impact

$BTSGBullishHigh confidence
Context

Q3 2026 revenue of $4.21B, net income $100.1M, EPS $0.45, with strong YoY growth across Pharmacy Solutions and Provider Services.

Expected impact

likely upside as market prices in strong top‑line growth and profit expansion.

Evidence & confidence

The quarterly numbers exceed prior year by double‑digits, indicating momentum that should lift the stock.

Market effects

Sector

Positive earnings may boost sentiment across the health‑services sector.

Regional

U.S. equity market, especially healthcare investors.

Global

Limited to U.S. healthcare exposure, modest global effect.

Counterpoint

What could challenge this read

Home and Community Pharmacy revenue declined 6.3%, which could weigh on margins.

Key entities

  • company
    BrightSpring Health Services

    U.S. health‑services provider reporting Q3 2026 results.

  • acquired business
    Amedisys

    Acquired pharmacy branch contributing $76.1M to quarterly revenue.

  • acquired business
    LHC

    Acquired pharmacy branch contributing $76.1M to quarterly revenue.

Read at source← All news

StoryBrightSpring posts Q3 2026 earnings beat, lifts FY2026 revenue and EBITDA outlook

Also covered by

5 outlets

Related articles

OCT 30
$BTSGMedAI 8/10

BrightSpring Health Services Q3 Earnings Call Highlights

BrightSpring Health Services (BTSG) reported Q3 revenue growth in Provider Services (31% to $481M) and Home Healthcare (50% to $288M), driven by acquisitions. EBITDA margins remained stable. The company raised its 2026 adjusted EBITDA outlook to $850M-$860M and expects $15.9B-$16.125B in revenue. It plans further acquisitions and sees potential in its primary care strategy.

finance.yahoo.com6 min
OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 30
$BTSGMedAI 9/10

BrightSpring (BTSG) Q3 2026 Earnings Call Transcript

BrightSpring (BTSG) reported Q3 2026 revenue of $4.2B (+26% YoY) and adjusted EBITDA of $228M (+42% YoY). CEO Jon Rousseau highlighted growth in Pharmacy Solutions and Provider Services, driven by increased demand and operational efficiency. The company's EPS rose 80% YoY to $0.54, with strong cash flow exceeding $200M. BrightSpring attributes its success to strategic M&A, scale, and complementary service offerings.

finance.yahoo.com6 min